Selective trafficking of light chain-conjugated nanoparticles to the kidney and renal cell carcinoma
Authors:
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Nano Today
- Vol. 35
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K08DK124685, T32DK007527)
- Dialysis Clinics
This publication has 50 references indexed in Scilit:
- World Incidence of AKIClinical Journal of the American Society of Nephrology, 2013
- The Current Role of Lymph Node Dissection in the Management of Renal Cell CarcinomaInternational Journal of Surgical Oncology, 2011
- Clinical Characteristics and Outcomes of Patients With Recurrence 5 Years After Nephrectomy for Localized Renal Cell CarcinomaJournal of Urology, 2011
- Imaging of the Porous Ultrastructure of the Glomerular Epithelial Filtration SlitJournal of the American Society of Nephrology, 2010
- Autosomal dominant polycystic kidney disease: the last 3 yearsKidney International, 2009
- Polycystic Kidney DiseaseAnnual Review of Medicine, 2009
- Molecular Classification of Renal Tumors by Gene Expression ProfilingThe Journal of Molecular Diagnostics, 2005
- Light chains are a ligand for megalinJournal of Applied Physiology, 2005
- Megalin and cubilin: multifunctional endocytic receptorsNature Reviews Molecular Cell Biology, 2002
- Megalin Knockout Mice as an Animal Model of Low Molecular Weight ProteinuriaThe American Journal of Pathology, 1999